Staar Surgical

STAAR Surgical Announces U.S. FDA Approval of EVO Visian® Implantable Collamer® Lenses

2022-03-28
Press release

STAAR Surgical Announces U.S. FDA Approval of EVO Visian® Implantable Collamer® Lenses

Next news

STAAR Surgical Reports Fourth Quarter and Full Year 2021 Results

STAAR Surgical to Report Fourth Quarter and Fiscal Year Results on February 23, 2022

STAAR Surgical Announces Preliminary Fourth Quarter and Full Year 2021 Results

STAAR Surgical Reports Third Quarter Net Sales of $58.4 Million Up 24% Y/Y

See all news